vs
Side-by-side financial comparison of MicroAlgo Inc. (MLGO) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $26.3M, roughly 1.2× MicroAlgo Inc.). On growth, RxSight, Inc. posted the faster year-over-year revenue change (-18.9% vs -35.5%).
MicroAlgo Inc. is a technology enterprise specializing in custom algorithm optimization solutions. It mainly serves clients across smart city management, industrial internet, and e-commerce sectors, helping enterprises improve operational efficiency, reduce operating costs, and optimize data processing performance for real business scenarios.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
MLGO vs RXST — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.3M | $32.6M |
| Net Profit | — | $-9.2M |
| Gross Margin | — | 77.5% |
| Operating Margin | — | -34.8% |
| Net Margin | — | -28.1% |
| Revenue YoY | -35.5% | -18.9% |
| Net Profit YoY | — | -54.1% |
| EPS (diluted) | — | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $32.6M | ||
| Q3 25 | — | $30.3M | ||
| Q2 25 | $26.3M | $33.6M | ||
| Q1 25 | — | $37.9M | ||
| Q4 24 | $34.6M | $40.2M | ||
| Q3 24 | — | $35.3M | ||
| Q2 24 | $40.8M | $34.9M | ||
| Q1 24 | — | $29.5M |
| Q4 25 | — | $-9.2M | ||
| Q3 25 | — | $-9.8M | ||
| Q2 25 | — | $-11.8M | ||
| Q1 25 | — | $-8.2M | ||
| Q4 24 | $4.2M | $-5.9M | ||
| Q3 24 | — | $-6.3M | ||
| Q2 24 | — | $-6.1M | ||
| Q1 24 | — | $-9.1M |
| Q4 25 | — | 77.5% | ||
| Q3 25 | — | 79.9% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 74.8% | ||
| Q4 24 | 26.4% | 71.6% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 70.1% |
| Q4 25 | — | -34.8% | ||
| Q3 25 | — | -40.1% | ||
| Q2 25 | — | -41.6% | ||
| Q1 25 | — | -28.2% | ||
| Q4 24 | 7.0% | -21.5% | ||
| Q3 24 | — | -26.1% | ||
| Q2 24 | — | -23.9% | ||
| Q1 24 | — | -36.2% |
| Q4 25 | — | -28.1% | ||
| Q3 25 | — | -32.4% | ||
| Q2 25 | — | -35.0% | ||
| Q1 25 | — | -21.6% | ||
| Q4 24 | 12.1% | -14.8% | ||
| Q3 24 | — | -17.9% | ||
| Q2 24 | — | -17.4% | ||
| Q1 24 | — | -30.8% |
| Q4 25 | — | $-0.22 | ||
| Q3 25 | — | $-0.24 | ||
| Q2 25 | — | $-0.29 | ||
| Q1 25 | — | $-0.20 | ||
| Q4 24 | $0.56 | $-0.14 | ||
| Q3 24 | — | $-0.16 | ||
| Q2 24 | — | $-0.16 | ||
| Q1 24 | — | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $319.4M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $317.6M | $275.7M |
| Total Assets | $330.8M | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $228.1M | ||
| Q3 25 | — | $227.5M | ||
| Q2 25 | $319.4M | $227.5M | ||
| Q1 25 | — | $229.3M | ||
| Q4 24 | $164.9M | $237.2M | ||
| Q3 24 | — | $237.1M | ||
| Q2 24 | $66.7M | $233.3M | ||
| Q1 24 | — | $125.4M |
| Q4 25 | — | $275.7M | ||
| Q3 25 | — | $276.0M | ||
| Q2 25 | $317.6M | $278.0M | ||
| Q1 25 | — | $279.3M | ||
| Q4 24 | $144.9M | $281.2M | ||
| Q3 24 | — | $277.3M | ||
| Q2 24 | $76.0M | $275.2M | ||
| Q1 24 | — | $163.9M |
| Q4 25 | — | $311.8M | ||
| Q3 25 | — | $308.5M | ||
| Q2 25 | $330.8M | $309.0M | ||
| Q1 25 | — | $313.0M | ||
| Q4 24 | $176.3M | $318.6M | ||
| Q3 24 | — | $310.5M | ||
| Q2 24 | $107.6M | $305.5M | ||
| Q1 24 | — | $183.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.1M |
| Free Cash FlowOCF − Capex | — | $-2.3M |
| FCF MarginFCF / Revenue | — | -6.9% |
| Capex IntensityCapex / Revenue | — | 3.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.1M | ||
| Q3 25 | — | $-1.2M | ||
| Q2 25 | — | $-4.4M | ||
| Q1 25 | — | $-8.8M | ||
| Q4 24 | $4.8M | $-4.3M | ||
| Q3 24 | — | $650.0K | ||
| Q2 24 | — | $-4.0M | ||
| Q1 24 | — | $-9.3M |
| Q4 25 | — | $-2.3M | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-5.9M | ||
| Q1 25 | — | $-9.4M | ||
| Q4 24 | $4.8M | $-5.1M | ||
| Q3 24 | — | $-453.0K | ||
| Q2 24 | — | $-5.5M | ||
| Q1 24 | — | $-11.3M |
| Q4 25 | — | -6.9% | ||
| Q3 25 | — | -5.8% | ||
| Q2 25 | — | -17.6% | ||
| Q1 25 | — | -24.8% | ||
| Q4 24 | 13.8% | -12.7% | ||
| Q3 24 | — | -1.3% | ||
| Q2 24 | — | -15.9% | ||
| Q1 24 | — | -38.2% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | 0.0% | 2.1% | ||
| Q3 24 | — | 3.1% | ||
| Q2 24 | 0.0% | 4.4% | ||
| Q1 24 | — | 6.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.15× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MLGO
Segment breakdown not available.
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
